Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Gibson

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 8, 2017
Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosisS L Heltshe, U Khan, V Beckett, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 29, 2011
Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosaC E Wainwright, A L Quittner, D E Geller, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 10, 2002
Estrogen-induced osteogenesis in intact female mice lacking ERbetaK E McDougall, M J Perry, R L Gibson, et al.
The Journal of Infectious Diseases|January 3, 2001
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosisJ L Burns, R L Gibson, S McNamara, et al.
The Journal of Clinical Investigation|March 15, 1996
Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosisJ Zabner, B W Ramsey, D P Meeker, et al.
The American Review of Respiratory Disease|July 1, 1993
Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosisB W Ramsey, S J Astley, M L Aitken, et al.
The New England Journal of Medicine|June 17, 1993
Efficacy of aerosolized tobramycin in patients with cystic fibrosisB W Ramsey, H L Dorkin, J D Eisenberg, et al.
Human Gene Therapy|October 9, 2001
A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung diseaseM L Aitken, R B Moss, D A Waltz, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 26, 2017
Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosisD R VanDevanter, S L Heltshe, J Spahr, et al.
Pediatric Pulmonology|October 12, 2001
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosisM Rosenfeld, R L Gibson, S McNamara, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 8, 2017
Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosisS L Heltshe, U Khan, V Beckett, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 29, 2011
Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosaC E Wainwright, A L Quittner, D E Geller, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 10, 2002
Estrogen-induced osteogenesis in intact female mice lacking ERbetaK E McDougall, M J Perry, R L Gibson, et al.
The Journal of Infectious Diseases|January 3, 2001
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosisJ L Burns, R L Gibson, S McNamara, et al.
The Journal of Clinical Investigation|March 15, 1996
Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosisJ Zabner, B W Ramsey, D P Meeker, et al.
The American Review of Respiratory Disease|July 1, 1993
Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosisB W Ramsey, S J Astley, M L Aitken, et al.
The New England Journal of Medicine|June 17, 1993
Efficacy of aerosolized tobramycin in patients with cystic fibrosisB W Ramsey, H L Dorkin, J D Eisenberg, et al.
Human Gene Therapy|October 9, 2001
A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung diseaseM L Aitken, R B Moss, D A Waltz, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 26, 2017
Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosisD R VanDevanter, S L Heltshe, J Spahr, et al.
Pediatric Pulmonology|October 12, 2001
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosisM Rosenfeld, R L Gibson, S McNamara, et al.
Pageof 6